Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Shenyuan CHEN"'
Autor:
Fengtian Sun, Yuntong Sun, Xiaoling Wang, Junyan Zhu, Shenyuan Chen, Yifan Yu, Mengyao Zhu, Wenrong Xu, Hui Qian
Publikováno v:
Bioactive Materials, Vol 33, Iss , Pp 444-459 (2024)
Diabetic retinopathy (DR) is a leading cause of blindness worldwide with limited treatment options. Mesenchymal stem cell-derived small extracellular vesicles (MSC-sEVs) hold promise as a cell-free therapy for retinal diseases. In this study, we pres
Externí odkaz:
https://doaj.org/article/5dc3bb7682334fc1bc2c5fe338a67e66
Autor:
Kewei Li, Zhong Liu, Peipei Wu, Shenyuan Chen, Min Wang, Wenhui Liu, Leilei Zhang, Song Guo, Yanbin Liu, Pengcheng Liu, Beiting Zhang, Lin Tao, Hua Ding, Hui Qian, Qiang Fu
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-17 (2023)
Abstract Spinal cord injury (SCI) is a traumatic condition of the central nervous system that causes paralysis of the limbs. Micro electric fields (EF) have been implicated in a novel therapeutic approach for nerve injury repair and regeneration, but
Externí odkaz:
https://doaj.org/article/733f57f11460409c8b3df94c83f7f5bf
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-17 (2023)
Abstract Photoreceptor apoptosis is an important pathogenesis of retinal degeneration and a primary cause of vision loss with limited treatment methods. Mesenchymal stem/stromal cells-derived small extracellular vesicles (MSC-sEVs) have shown therape
Externí odkaz:
https://doaj.org/article/f604d3f8bb58473ab3164da635f99362
Autor:
Fengtian Sun, Yuntong Sun, Junyan Zhu, Xiaoling Wang, Cheng Ji, Jiahui Zhang, Shenyuan Chen, Yifan Yu, Wenrong Xu, Hui Qian
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-15 (2022)
Abstract Background As a leading cause of vision decline and severe blindness in adults, diabetic retinopathy (DR) is characterized by the aggravation of retinal oxidative stress and apoptosis in the early stage. Emerging studies reveal that mesenchy
Externí odkaz:
https://doaj.org/article/820c3decf91e4facaa0f2dc7bf55780f
Publikováno v:
Stem Cells International, Vol 2022 (2022)
Mesenchymal stem cells (MSCs) have been widely applied to regenerative medicine owing to their multiple differentiation, self-renewal, and immunomodulatory abilities. Exosomes are cell-secreted natural nanovesicles and thought to be mediators of inte
Externí odkaz:
https://doaj.org/article/7ee6ec71beb046f08b7a7b96693152f3
Autor:
Zhiguo, Fan, Ji, Wu, Shenyuan, Chen, Guoyou, Zhang, Chen, Kai, Hui, Qian, Wenrong, Xu, Zhai, Xiao
Publikováno v:
Journal of Nanobiotechnology; 8/23/2023, Vol. 21 Issue 1, p1-18, 18p
Autor:
Fengtian Sun, Yuntong Sun, Junyan Zhu, Xiaoling Wang, Cheng Ji, Jiahui Zhang, Shenyuan Chen, Yifan Yu, Wenrong Xu, Hui Qian
Publikováno v:
Stem cell researchtherapy. 13(1)
Background As a leading cause of vision decline and severe blindness in adults, diabetic retinopathy (DR) is characterized by the aggravation of retinal oxidative stress and apoptosis in the early stage. Emerging studies reveal that mesenchymal stem
Autor:
Joel Jules, Yuyu Li, Robert A. Kesterson, Dongfeng Zhao, Ping Zhang, Xu Feng, Zhenqi Shi, Shenyuan Chen
Publikováno v:
J Bone Miner Res
Upon receptor activator of NF-κB ligand (RANKL) binding, RANK promotes osteoclast formation through the recruitment of tumor necrosis factor (TNF) receptor-associated factors (TRAFs). In vitro assays identified two RANK intracellular motifs that bin
Autor:
Shenyuan Chen, Yuanyuan Ma, Xiangnan Wu, Zhichao Hao, Helin Chen, Taozi Fu, Xianxian Li, Hang Wang
Publikováno v:
Archives of Oral Biology. 60:789-798
Objective 5-Hydroxytryptophan (5-HTP) is the precursor of serotonin and 5-HTP has been widely used as a dietary supplement to raise serotonin level. Serotonin has recently been discovered to be a novel and important player in bone metabolism. As peri
Autor:
Daoyuan Gong, Xin Chen, Ruixue Wang, Chaohui Duan, Yunuo Wang, ShenYuan Chen, Lian Liu, Yong Wang, Shuhong Luo
Publikováno v:
Cytokine. 125:154810
Prostate cancer (CaP) is a common male malignancy. Using prostate specific antigen (PSA) and prostate cancer antigen 3 (PCA3) in the diagnosis of prostate cancer, sensitivity and specificity still require improvement. Additional targets are urgently